ADVANCED ENZYME TECH LTD

170.4 -0.55 (-0.32%) Sell

Search for alternative investments is on for ADVENZYMES investors as it underperforms

13 min read

ADVENZYMES underperformed broader market today. On a longer term basis, investors in ADVANCED ENZYME TECH LTD made -0.02% per day. Friday's performance of -0.32% was a significant underperformance compared to it's daily average.

[Themes containing ADVENZYMES]

Buy-and-Hold investors in ADVENZYMES experienced a maximum drawdown of -16.67% over the last three months. It returned -8.53% during this down trending period. There were both Long and Short signals during this period, where the short signals were significantly more profitable than the long signals. The net profit from Short signals was +3.34%.

Trend

ADVENZYMES has been underperforming the NIFTY-50 index in recent time, after having outperformed till 25 Oct, 2016. ADVENZYMES is currently at it's worst performance to the NIFTY-50 index and therefore does not make a good investment candidate. Over the last 2 years and 6 months, ADVENZYMES underperformed the NIFTY-50 index on 57% days.

During the last three months ADVENZYMES was mostly loss making and delivered on average -0.13% per day. It's best return during this period (of +7.27%) was on Wednesday, 31 Oct, 2018. While it's worst loss in the same period (of -4.54%) was on Friday, 2 Nov, 2018. There was initially a bullish trend during this period which started on 11 Dec, 2018 and went on till 14 Dec, 2018. The bullish trend returned +6.89% to investors. This was followed by a bearish trend that started on 28 Dec, 2018 and ended on 7 Jan, 2019. This bearish trend lost -4.98% of investor capital.

On monthly basis, ADVENZYMES delivered losses in more months over the last year, than profits. ADVENZYMES delivered profits less regularly than NIFTY-50 index. ADVENZYMES significantly outperformed NIFTY-50 index in Apr 2018, when it returned +19.06% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. ADVENZYMES had a longer winning streak of losing months than NIFTY-50 index. It went down in 5 straight months (from May 2018 to Sep 2018) during which period it delivered -28.08%. It is interesting to note that both ADVENZYMES and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

"It is well enough that people of the nation do not understand our banking and monetary system, for if they did, I believe there would be a revolution before tomorrow morning.

ADVENZYMES is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant fall in ADVENZYMES's volatility from 22 Oct, 2018 to 15 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that ADVENZYMES has significant negative skewness in it's return distribution. This indicates that ADVENZYMES is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than ADVENZYMES. Therefore, NIFTY-50 must receive a lower allocation than ADVENZYMES in your portfolio. NIFTY-50 index usually has shorter drawdown period than ADVENZYMES.

On a general note (since you are interested in ADVENZYMES), VINATIORGA is a small cap that deserves to be closely tracked for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter